157 related articles for article (PubMed ID: 11036044)
1. Protection against lipopolysaccharide-induced death by fluoroquinolones.
Khan AA; Slifer TR; Araujo FG; Suzuki Y; Remington JS
Antimicrob Agents Chemother; 2000 Nov; 44(11):3169-73. PubMed ID: 11036044
[TBL] [Abstract][Full Text] [Related]
2. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion.
Shapira L; Soskolne WA; Houri Y; Barak V; Halabi A; Stabholz A
Infect Immun; 1996 Mar; 64(3):825-8. PubMed ID: 8641787
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment of mice with clindamycin improves survival of endotoxic shock by modulating the release of inflammatory cytokines.
Hirata N; Hiramatsu K; Kishi K; Yamasaki T; Ichimiya T; Nasu M
Antimicrob Agents Chemother; 2001 Sep; 45(9):2638-42. PubMed ID: 11502543
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model.
Lacy MK; Nicolau DP; Banevicius MA; Nightingale CH; Quintiliani R
J Antimicrob Chemother; 1999 Oct; 44(4):477-81. PubMed ID: 10588309
[TBL] [Abstract][Full Text] [Related]
5. The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin.
Purswani M; Eckert S; Arora H; Johann-Liang R; Noel GJ
J Antimicrob Chemother; 2000 Dec; 46(6):921-9. PubMed ID: 11102411
[TBL] [Abstract][Full Text] [Related]
6. Effect of trovafloxacin on production of cytokines by human monocytes.
Khan AA; Slifer TR; Remington JS
Antimicrob Agents Chemother; 1998 Jul; 42(7):1713-7. PubMed ID: 9661009
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.
Shaw PJ; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2009 Jan; 328(1):62-8. PubMed ID: 18820134
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of trovafloxacin in the treatment of Klebsiella pneumoniae lung infection in tumour-bearing mice.
Thadepalli H; Reddy U; Chuah SK; Hanna N; Rana G; Gollapudi S
J Antimicrob Chemother; 2000 Jan; 45(1):69-75. PubMed ID: 10629015
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro effects of fluoroquinolones on lipopolysaccharide-induced pro-inflammatory cytokine production.
Ogino H; Fujii M; Ono M; Maezawa K; Hori S; Kizu J
J Infect Chemother; 2009 Jun; 15(3):168-73. PubMed ID: 19554401
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of transmembrane TNF-α shedding by a specific antibody protects against septic shock.
Li C; Gu H; Yu M; Yang P; Zhang M; Ba H; Yin Y; Wang J; Yin B; Zhou X; Li Z
Cell Death Dis; 2019 Aug; 10(8):586. PubMed ID: 31383857
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of taraxasterol against LPS-induced endotoxic shock by modulating inflammatory responses in mice.
Zhang X; Xiong H; Li H; Cheng Y
Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):11-6. PubMed ID: 24286370
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of wogonin on endotoxin-induced lethal shock in D-galactosamine-sensitized mice.
Van Dien M; Takahashi K; Mu MM; Koide N; Sugiyama T; Mori I; Yoshida T; Yokochi T
Microbiol Immunol; 2001; 45(11):751-6. PubMed ID: 11791668
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment of mice with rifampicin prolongs survival of endotoxic shock by modulating the levels of inflammatory cytokines.
An N; Song Y; Zhang X; Ci X; Li H; Cao Y; Zhang M; Cui J; Deng X
Immunopharmacol Immunotoxicol; 2008; 30(3):437-46. PubMed ID: 18618311
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs.
Sugar AM; Liu XP; Chen RJ
Antimicrob Agents Chemother; 1997 Nov; 41(11):2518-21. PubMed ID: 9371359
[TBL] [Abstract][Full Text] [Related]
15. The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production.
Greeneltch KM; Haudenschild CC; Keegan AD; Shi Y
Brain Behav Immun; 2004 Sep; 18(5):476-84. PubMed ID: 15265541
[TBL] [Abstract][Full Text] [Related]
16. A novel xanthine derivative counteracting in vivo tumor necrosis factor alpha toxicity in mice.
Niehörster M; Schönharting M; Wendel A
Circ Shock; 1992 Aug; 37(4):270-3. PubMed ID: 1446384
[TBL] [Abstract][Full Text] [Related]
17. Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide-induced acute lung injuries.
Huang HC; Shieh CC; Yu WL; Cheng KC; Chen CC; Chang ST; Chuang YC
Respirology; 2008 Jan; 13(1):47-52. PubMed ID: 18197910
[TBL] [Abstract][Full Text] [Related]
18. Trovafloxacin is active against Toxoplasma gondii.
Khan AA; Slifer T; Araujo FG; Remington JS
Antimicrob Agents Chemother; 1996 Aug; 40(8):1855-9. PubMed ID: 8843293
[TBL] [Abstract][Full Text] [Related]
19. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice.
Gallay P; Heumann D; Le Roy D; Barras C; Glauser MP
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7922-6. PubMed ID: 7520172
[TBL] [Abstract][Full Text] [Related]
20. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production.
Muchamuel T; Menon S; Pisacane P; Howard MC; Cockayne DA
J Immunol; 1997 Mar; 158(6):2898-903. PubMed ID: 9058827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
